EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | H2O.C21H23N3O5 |
| Net Charge | 0 |
| Average Mass | 415.446 |
| Monoisotopic Mass | 415.17434 |
| SMILES | CC[C@@H](Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccc(C)o1.O |
| InChI | InChI=1S/C21H23N3O5.H2O/c1-5-13(15-10-9-11(2)29-15)22-16-17(20(27)19(16)26)23-14-8-6-7-12(18(14)25)21(28)24(3)4;/h6-10,13,22-23,25H,5H2,1-4H3;1H2/t13-;/m1./s1 |
| InChIKey | AFTCWZSEWTXWTL-BTQNPOSSSA-N |
| Roles Classification |
|---|
| Applications: | anti-asthmatic agent Any compound that has anti-asthmatic effects. antipsoriatic A drug used to treat psoriasis. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| navarixin (CHEBI:750502) has role anti-asthmatic agent (CHEBI:65023) |
| navarixin (CHEBI:750502) has role antipsoriatic (CHEBI:50748) |
| navarixin (CHEBI:750502) is a salicylamides (CHEBI:53443) |
| INN | Source |
|---|---|
| navarixin | WHO MedNet |
| Synonyms | Source |
|---|---|
| MK-7123 MONOHYDRATE | ChEMBL |
| Navarixin monohydrate | ChEMBL |
| PS-291822 | ChEMBL |
| PS291822 | ChEMBL |
| SCH 527123 | ChEMBL |
| SCH-527123 MONOHYDRATE | ChEMBL |